New York State Teachers Retirement System Lowers Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

New York State Teachers Retirement System trimmed its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 6.5% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 57,790 shares of the company's stock after selling 4,000 shares during the period. New York State Teachers Retirement System owned about 0.12% of Prestige Consumer Healthcare worth $4,513,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC grew its position in Prestige Consumer Healthcare by 3.1% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company's stock worth $126,274,000 after purchasing an additional 49,331 shares in the last quarter. Meritage Portfolio Management grew its position in Prestige Consumer Healthcare by 7.0% in the 4th quarter. Meritage Portfolio Management now owns 12,826 shares of the company's stock worth $1,002,000 after purchasing an additional 834 shares in the last quarter. Choreo LLC grew its position in Prestige Consumer Healthcare by 29.9% in the 4th quarter. Choreo LLC now owns 14,100 shares of the company's stock worth $1,091,000 after purchasing an additional 3,249 shares in the last quarter. Longboard Asset Management LP bought a new position in shares of Prestige Consumer Healthcare during the 4th quarter valued at approximately $201,000. Finally, Alliance Wealth Advisors LLC UT grew its position in shares of Prestige Consumer Healthcare by 6.2% during the 4th quarter. Alliance Wealth Advisors LLC UT now owns 11,529 shares of the company's stock valued at $900,000 after acquiring an additional 672 shares during the period. 99.95% of the stock is owned by institutional investors.

Prestige Consumer Healthcare Stock Performance

PBH traded down $0.13 on Friday, hitting $84.66. The company's stock had a trading volume of 294,102 shares, compared to its average volume of 313,679. The company's 50 day simple moving average is $79.42 and its 200-day simple moving average is $76.38. The firm has a market cap of $4.19 billion, a P/E ratio of 19.83, a price-to-earnings-growth ratio of 2.69 and a beta of 0.50. Prestige Consumer Healthcare Inc. has a 12 month low of $62.35 and a 12 month high of $88.36. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Analysts Set New Price Targets

PBH has been the subject of a number of research reports. Oppenheimer increased their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a research report on Thursday, February 13th. DA Davidson increased their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a research report on Friday, February 7th. StockNews.com raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Friday, January 24th. Canaccord Genuity Group increased their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Finally, Sidoti downgraded shares of Prestige Consumer Healthcare from a "buy" rating to a "neutral" rating and set a $90.00 target price for the company. in a research report on Monday, December 9th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $92.60.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.